Power Life Sciences
Open enrollment across a mixed-phase pipeline
According to ClinicalTrials.gov-derived indexes, Power Life Sciences sits in the top decile of US sponsors by registered trial count (#332 of 15,742 sponsors by registered trial count).
Power Life Sciences: 62 sponsored US clinical trials, 1 recruiting.
Power Life Sciences sponsors 62 registered US clinical trials on ClinicalTrials.gov, 1 of them currently recruiting. The most-studied condition in this pipeline is OCD, with 1 trials.
Top-decile sponsor footprint
Power Life Sciences ranks in the top decile of sponsors by registered trial count (#332 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Open and recent trials
62 total, page 1 of 2
Discovering Factors in the Clinical Study Journey of Patients With OCD
NCT05881356
Exploring Acne Treatments Through Clinical Research Participation
NCT07010458
Examining Engagement Trends Among Participants in Peripheral Neuropathy Clinical Research
NCT06338384
Understanding Participation Habits Among Plaque Psoriasis Patients
NCT06338358
Delving Into Participation Trends of Scleroderma Clinical Trials
NCT06264492
Investigative Analysis of Soft Tissue Sarcoma Clinical Trials: An Observational Study
NCT06264505
Assessing Patient Engagement in Keratoconus Clinical Research
NCT06288737
Understanding Patient Engagement Trends in TBI Clinical Research
NCT06288698
An Observational Exploration of Clinical Trials Targeting Traumatic Brain Injury
NCT06264518
Understanding of Participation Trends Within Generalized Anxiety Disorder Patients Involved in Clinical Trials
NCT06254157
Studying Patterns in Patient Engagement Among Tardive Dyskinesia Patients
NCT06218719
Exploring Clinical Study Experiences of People With Anorexia Nervosa
NCT06207890
Revealing Engagement Dynamics Among Semantic Dementia Patients
NCT06218732
Navigating the Clinical Research Process for Mild Cognitive Impairment
NCT06207903
Investigating Participation Patterns of Patients in Atopic Dermatitis Clinical Trials
NCT06174493
A Journey Into Participation Patterns Among Patients With Hidradenitis Suppurativa
NCT06201858
Revealing Engagement Patterns Among Hepatic Encephalopathy Patients
NCT06201988
Insights Into Participating in Clinical Studies for Anorexia
NCT06146075
Exploring Clinical Study Experiences of People With Post Traumatic Stress Disorder
NCT06146049
Understanding Patient Engagement Trends in Anxiety Disorder Clinical Research
NCT06155565
Evaluating the Occurrence of Participation Trends Among Weight Loss Clinical Trials Patients
NCT06155552
A Detailed Look At What Patients Experience In Medullary Thyroid Cancer Clinical Study
NCT06079723
Investigating Participation Patterns Among Stage IV Melanoma Patients
NCT06093594
Delving Into Participation Trends in Renal Cell Carcinoma Studies
NCT06093568
Studying Patterns in Patient Engagement Among Treatment Resistant Depression Patients
NCT06101914
Revealing Engagement Dynamics Among Diabetic Kidney Disease Patients
NCT06101901
Analyzing Engagement Trends in Rhabdomyosarcoma Clinical Trials
NCT06029465
Investigating Participation Patterns Among Recurrent Ovarian Cancer Patients
NCT06070285
Insights Into Participating in Studies for Bone Cancer
NCT06070259
Understanding Engagement Trends in Chondrosarcoma Clinical Trials
NCT06029478
Exploring Merkel Cell Carcinoma Clinical Trial Engagement Patterns
NCT06039033
Patient Perspectives in Mantle Cell Lymphoma Clinical Research
NCT06049472
Determining Patterns In Trial Experiences of Recurrent Prostate Cancer Patients
NCT06070272
Investigating Engagement Patterns and Participation Trends Among Liposarcoma Patients
NCT06039046
Navigating the Clinical Research Process for Lymphoma
NCT06070246
Assessing the Experience of Patients Undergoing Follicular Lymphoma Clinical Research
NCT06049485
Insights Into Participating in Studies for Uterine Cancer
NCT05998811
Delving Into Borderline Personality Disorder Clinical Trial Experiences
NCT05989529
Revealing Engagement Patterns Among Endometrial Cancer Patients
NCT05998798
A Journey Into Participation Patterns Among Metastatic Prostate Cancer Patients
NCT06009549
Delving Into Participation Patterns in Social Anxiety Studies
NCT06020170
Analyzing Clinical Trial Experiences of Prostate Cancer Patients
NCT05411354
Exploring Engagement Dynamics Among Individuals Impacted by Bladder Cancer
NCT06009510
Evaluating Factors In Study Experiences of Lymphedema Patients
NCT05948345
Discovering Trends in Chronic Fatigue Syndrome Patients' Clinical Study Experiences
NCT05967494
Appraising Clinical Trial Experiences of Patients With Insomnia
NCT05978271
Evaluation of Study Experiences of Neuroendocrine Tumor Patients
NCT05967481
A Close Examination of Patient Experiences in Cluster Headache Clinical Research
NCT05978258
Assessment of Schizophrenia Patients' Clinical Study Experiences
NCT05948111
Medical Trial: Appraising Medical Trial Experiences of Rheumatoid Arthritis Patients
NCT05398471
Therapeutic Areas
What is open in the Power Life Sciences pipeline
1 recruiting of 62 indexed (2% open).
Phase labels are sparse on this sponsor index, so phase mix is not charted here.
Top condition: OCD (1 trial), 1 other listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
Power Life Sciences: open-pipeline peers nationwide
Peers matched on 62 registered trials and 2% open enrollment, not the therapeutic-area sidebar.
Power Life Sciences sits below the median trial volume and below the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 62 trials (± recruiting share)
- Oregon Research Institute · 62 trials · 8% recruiting
- Actelion · 63 trials · 0% recruiting
- Hennepin Healthcare Research Institute · 63 trials · 6% recruiting
- United Therapeutics · 63 trials · 8% recruiting
Sponsors near 2% open enrollment (± trial volume)
- Bausch & Lomb Incorporated · 2% recruiting · 174 trials
- Medtronic Cardiac Rhythm and Heart Failure · 2% recruiting · 115 trials
- Eisai · 2% recruiting · 287 trials
- Lexicon Pharmaceuticals · 2% recruiting · 56 trials
Related
What to do with this Power Life Sciences page
62 registered trials is a research-attention snapshot, not an endorsement of Power Life Sciences or any single study.
- 1 of Power Life Sciences's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- OCD is the condition Power Life Sciences studies most, compare against other sponsors active in the same condition before evaluating a specific study. See OCD trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Power Life Sciences pipeline card: 62 registered trials from official public datasets.Report a data error.